| 1 | 1 | | CALIFORNIA LEGISLATURE 20252026 REGULAR SESSION Senate Concurrent Resolution No. 68Introduced by Senator Blakespear(Coauthor: Senator Ochoa Bogh)(Coauthors: Assembly Members Jeff Gonzalez and Stefani)April 28, 2025 Relative to Tardive Dyskinesia Awareness Week. LEGISLATIVE COUNSEL'S DIGESTSCR 68, as introduced, Blakespear. Tardive Dyskinesia Awareness Week.This measure would declare the week of May 5, 2025, as Tardive Dyskinesia Awareness Week. Digest Key Fiscal Committee: NO Bill TextWHEREAS, Serious mental illnesses like bipolar disorder, major depressive disorder, and schizophrenia often require treatment with antipsychotic medications for effective management, and antipsychotic prescribing rates continue to rise; andWHEREAS, While prolonged antipsychotic use may be essential for the treatment of certain conditions, it is associated with tardive dyskinesia (TD), a condition marked by uncontrollable, abnormal, and repetitive movements of the face, torso, limbs, or extremities; andWHEREAS, People at higher risk of TD include those over 55 years of age, Black individuals, women, individuals with mood or substance use disorders, intellectual disabilities, or central nervous system injuries, and those with high cumulative antipsychotic exposure; andWHEREAS, Approximately 60 percent of the estimated 800,000 adults in the United States living with TD remain undiagnosed. Even mild TD symptoms can be stigmatizing and impair physical, social, and emotional well-being, which underscores the urgency of early screening, detection, and intervention; andWHEREAS, The American Psychiatric Association recommends routine TD screening in its clinical guidelines for antipsychotic treatment, and individuals treated with antipsychotics or experiencing abnormal movements should consult their health care providers to assess TD risk, receive TD screenings, and determine appropriate treatment together; andWHEREAS, Federal Food and Drug Administration-approved treatments for TD can provide options for symptom management and improve quality of life for many individuals living with TD; andWHEREAS, The Senate encourages TD screening education and awareness for health care providers, patients, and care partners to help ensure patients prescribed antipsychotics receive care and support that aligns with clinical best practices, including regular TD screenings; now, therefore, be it Resolved by the Senate of the State of California, the Assembly thereof concurring, That the Senate declares the week of May 5, 2025, as Tardive Dyskinesia Awareness Week (TDAW); and be it furtherResolved, That in recognition and support of TDAW, the Senate underscores the importance of early detection and intervention to improve outcomes for people living with mental health conditions and prescribed antipsychotics, and supports efforts to raise awareness about the causes and symptoms of TD and the importance of routine TD screenings; and be it furtherResolved, That the Secretary of the Senate transmit copies of this resolution to the author for appropriate distribution. |
|---|
| 2 | 2 | | |
|---|
| 3 | 3 | | CALIFORNIA LEGISLATURE 20252026 REGULAR SESSION Senate Concurrent Resolution No. 68Introduced by Senator Blakespear(Coauthor: Senator Ochoa Bogh)(Coauthors: Assembly Members Jeff Gonzalez and Stefani)April 28, 2025 Relative to Tardive Dyskinesia Awareness Week. LEGISLATIVE COUNSEL'S DIGESTSCR 68, as introduced, Blakespear. Tardive Dyskinesia Awareness Week.This measure would declare the week of May 5, 2025, as Tardive Dyskinesia Awareness Week. Digest Key Fiscal Committee: NO |
|---|
| 4 | 4 | | |
|---|
| 5 | 5 | | |
|---|
| 6 | 6 | | |
|---|
| 7 | 7 | | |
|---|
| 8 | 8 | | |
|---|
| 9 | 9 | | CALIFORNIA LEGISLATURE 20252026 REGULAR SESSION |
|---|
| 10 | 10 | | |
|---|
| 11 | 11 | | Senate Concurrent Resolution |
|---|
| 12 | 12 | | |
|---|
| 13 | 13 | | No. 68 |
|---|
| 14 | 14 | | |
|---|
| 15 | 15 | | Introduced by Senator Blakespear(Coauthor: Senator Ochoa Bogh)(Coauthors: Assembly Members Jeff Gonzalez and Stefani)April 28, 2025 |
|---|
| 16 | 16 | | |
|---|
| 17 | 17 | | Introduced by Senator Blakespear(Coauthor: Senator Ochoa Bogh)(Coauthors: Assembly Members Jeff Gonzalez and Stefani) |
|---|
| 18 | 18 | | April 28, 2025 |
|---|
| 19 | 19 | | |
|---|
| 20 | 20 | | |
|---|
| 21 | 21 | | |
|---|
| 22 | 22 | | Relative to Tardive Dyskinesia Awareness Week. |
|---|
| 23 | 23 | | |
|---|
| 24 | 24 | | LEGISLATIVE COUNSEL'S DIGEST |
|---|
| 25 | 25 | | |
|---|
| 26 | 26 | | ## LEGISLATIVE COUNSEL'S DIGEST |
|---|
| 27 | 27 | | |
|---|
| 28 | 28 | | SCR 68, as introduced, Blakespear. Tardive Dyskinesia Awareness Week. |
|---|
| 29 | 29 | | |
|---|
| 30 | 30 | | This measure would declare the week of May 5, 2025, as Tardive Dyskinesia Awareness Week. |
|---|
| 31 | 31 | | |
|---|
| 32 | 32 | | This measure would declare the week of May 5, 2025, as Tardive Dyskinesia Awareness Week. |
|---|
| 33 | 33 | | |
|---|
| 34 | 34 | | ## Digest Key |
|---|
| 35 | 35 | | |
|---|
| 36 | 36 | | ## Bill Text |
|---|
| 37 | 37 | | |
|---|
| 38 | 38 | | WHEREAS, Serious mental illnesses like bipolar disorder, major depressive disorder, and schizophrenia often require treatment with antipsychotic medications for effective management, and antipsychotic prescribing rates continue to rise; and |
|---|
| 39 | 39 | | |
|---|
| 40 | 40 | | WHEREAS, While prolonged antipsychotic use may be essential for the treatment of certain conditions, it is associated with tardive dyskinesia (TD), a condition marked by uncontrollable, abnormal, and repetitive movements of the face, torso, limbs, or extremities; and |
|---|
| 41 | 41 | | |
|---|
| 42 | 42 | | WHEREAS, People at higher risk of TD include those over 55 years of age, Black individuals, women, individuals with mood or substance use disorders, intellectual disabilities, or central nervous system injuries, and those with high cumulative antipsychotic exposure; and |
|---|
| 43 | 43 | | |
|---|
| 44 | 44 | | WHEREAS, Approximately 60 percent of the estimated 800,000 adults in the United States living with TD remain undiagnosed. Even mild TD symptoms can be stigmatizing and impair physical, social, and emotional well-being, which underscores the urgency of early screening, detection, and intervention; and |
|---|
| 45 | 45 | | |
|---|
| 46 | 46 | | WHEREAS, The American Psychiatric Association recommends routine TD screening in its clinical guidelines for antipsychotic treatment, and individuals treated with antipsychotics or experiencing abnormal movements should consult their health care providers to assess TD risk, receive TD screenings, and determine appropriate treatment together; and |
|---|
| 47 | 47 | | |
|---|
| 48 | 48 | | WHEREAS, Federal Food and Drug Administration-approved treatments for TD can provide options for symptom management and improve quality of life for many individuals living with TD; and |
|---|
| 49 | 49 | | |
|---|
| 50 | 50 | | WHEREAS, The Senate encourages TD screening education and awareness for health care providers, patients, and care partners to help ensure patients prescribed antipsychotics receive care and support that aligns with clinical best practices, including regular TD screenings; now, therefore, be it |
|---|
| 51 | 51 | | |
|---|
| 52 | 52 | | Resolved by the Senate of the State of California, the Assembly thereof concurring, That the Senate declares the week of May 5, 2025, as Tardive Dyskinesia Awareness Week (TDAW); and be it further |
|---|
| 53 | 53 | | |
|---|
| 54 | 54 | | Resolved, That in recognition and support of TDAW, the Senate underscores the importance of early detection and intervention to improve outcomes for people living with mental health conditions and prescribed antipsychotics, and supports efforts to raise awareness about the causes and symptoms of TD and the importance of routine TD screenings; and be it further |
|---|
| 55 | 55 | | |
|---|
| 56 | 56 | | Resolved, That the Secretary of the Senate transmit copies of this resolution to the author for appropriate distribution. |
|---|